KIORA PHARMACEUTICALS INC (KPRX) Stock Cash Flow
NASDAQ:KPRX - US49721T5074 - Common Stock
2.7 USD
+0.02 (+0.75%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -11.98M | 3.59M | -12.51M | -13.58M | -13.77M | |||
| Depreciation Amortization | 11.70K | 19.20K | 51.80K | 40.00K | 50.00K | |||
| Income Taxes - Deferred | N/A | -288.80K | 90.30K | -110.00K | -190.00K | |||
| Change In Working Capital | 2.40M | 3.67M | -1.82M | 670.00K | -1.04M | |||
| Other non cash items | 2.02M | 1.57M | 4.64M | 2.56M | 4.28M | |||
| OPERATING CASH FLOW | -7.84M | 8.56M | -9.56M | -10.43M | -10.68M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -6.30K | N/A | 0.00 | -60.00K | |||
| Other Investing Activity | 1.89M | -22.66M | 0.00 | 10.00K | -90.00K | |||
| INVESTING CASH FLOW | 1.90M | -22.66M | 0.00 | 10.00K | -160.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | -210.00K | |||
| Stock Issued/Repurchased | 265.40K | 1.69M | 6.02M | 8.64M | 18.80M | |||
| Other Financing Activity | 0.00 | 13.81M | -52.70K | -20.00K | -1.00M | |||
| FINANCING CASH FLOW | 265.40K | 15.50M | 5.97M | 8.62M | 17.58M | |||
| Exchange Rate Effect | 128.60K | -57.20K | 36.00K | -90.00K | -80.00K | |||
| CHANGE IN CASH | -5.55M | 1.34M | -3.55M | -1.89M | 6.66M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -7.84M | 8.56M | -9.56M | -10.43M | -10.68M | |||
| Capital Expenditure | N/A | -6.30K | N/A | 0.00 | -60.00K | |||
| FREE CASH FLOW | -7.83M | 8.55M | -9.56M | -10.43M | -10.74M | |||
All data in USD